Brand Generic

Bad Blood

Share
Sold By (5 of 5 Ratings)
HIGHLIGHTS
  • Print Length: 350 pages

  • Publisher: Picador; Main Market edition (31 May 2018

  • Language: English

View all item details
STOCK
Available
EASY RETURNS
Available
WARRANTY
1 Year on manufacturing defects
KSh 1550
KSh 3100
50% OFF
Pay Only KSh 465 Now
Remaining on delivery*
*Select Part Payment at Checkout
ESTIMATED DELIVERY TIME

2 to 5 business days

  • Free Shipping in Nairobi for all prepaid orders above 2500 KSH use code FS2022
  • Get extra 10% off-use Coupon code DC2020 on prepaid orders

Description

The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.

In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.

In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

Reviews & Ratings

out of 5
0 Ratings & 0 Reviews
  • 5 star
    0
  • 4 star
    0
  • 3 star
    0
  • 2 star
    0
  • 1 star
    0
Have you used this product? Rate it now.

Recommended Products